Neuropsychobiology

Biological Psychiatry. Editor: J. Mendlewicz (Brussels) / Original Paper

Diffusion Tensor Magnetic Resonance Imaging of Disruption of Regional White Matter in Schizophrenia

Minami T.a · Nobuhara K.a · Okugawa G.a · Takase K.a · Yoshida T.a · Sawada S.b · Ha-Kawa S.b · Ikeda K.b · Kinoshita T.a

Author affiliations

Departments of aNeuropsychiatry and bRadiology, Kansai Medical University, Osaka, Japan

Related Articles for ""

Neuropsychobiology 2003;47:141–145

Log in to MyKarger to check if you already have access to this content.


Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!


If you would like to redeem your KAB credit, please log in.


Save over 20% compared to the individual article price.

Learn more

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply

Rental: USD 8.50
Cloud: USD 20.00

Select

Subscribe

  • Access to all articles of the subscribed year(s) guaranteed for 5 years
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates


Select
* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview
Abstract of Biological Psychiatry. Editor: J. Mendlewicz (Brussels) / Original Paper

Published online: May 21, 2003
Issue release date: May 2003

Number of Print Pages: 5
Number of Figures: 3
Number of Tables: 1

ISSN: 0302-282X (Print)
eISSN: 1423-0224 (Online)

For additional information: https://www.karger.com/NPS

Abstract

Diffusion tensor imaging provides a new approach for quantifying anisotropic diffusion of white matter in vivo. We used this technique to investigate subtle disruption of regional white matter in schizophrenia. Twelve patients with schizophrenia were compared with 11 healthy controls. Psychotic symptoms were assessed using the Positive and Negative Syndrome Scale. A significant fractional anisotropy (FA) reduction was found in all white matter regions bilaterally in schizophrenic patients. Higher FA of left frontal white matter correlated significantly with higher dosage of antipsychotic medication. These findings support the view that the pathological process is a distortion of the central nervous system myelination affecting the whole white matter. Our findings also show the effects of antipsychotics on the white matter in the left frontal region in schizophrenia.

© 2003 S. Karger AG, Basel




Related Articles:


References

  1. Le Bihan D, Mangin JF, Poupon C, Clark CA, Pappata S, Molko N, Chabriat H: Diffusion tensor imaging: Concepts and applications. J Magn Reson Imaging 2001;13:534–546.
  2. Makris N, Worth AJ, Sorensen AG, Papadimitriou GM, Wu O, Reese TG, Wedeen VJ, Davis TL, Stakes JW, Caviness VS, Kaplan E, Rosen BR, Pandya DN, Kennedy DN: Morphometry of in vivo human white matter association pathways with diffusion-weighted magnetic resonance imaging. Ann Neurol 1997;42:951–962.
  3. Wimberger DM, Roberts TP, Barkovich AJ, Prayer LM, Moseley ME, Kucharczyk J: Identification of ‘premyelination’ by diffusion-weighted MRI. J Comput Assist Tomogr 1995;19:28–33.
  4. Nakada T, Matsuzawa H: Three-dimensional anisotropy contrast magnetic resonance imaging of the rat nervous system: MR axonography. Neurosci Res 1995;22:389–398.
  5. Basser PJ, Mattiello J, LeBihan D: Estimation of the effective self-diffusion tensor from the NMR spin echo. J Magn Reson B 1994;103:247–254.
  6. Moseley ME, Cohen Y, Kucharczyk J, Mintorovitch J, Asgari HS, Wendland MF, Tsuruda J, Norman D: Diffusion-weighted MR imaging of anisotropic water diffusion in cat central nervous system. Radiology 1990;176:439–445.
  7. Werring DJ, Clark CA, Parker GJ, Miller DH, Thompson AJ, Barker GJ: A direct demonstration of both structure and function in the visual system: Combining diffusion tensor imaging with functional magnetic resonance imaging. Neuroimage 1999;9:352–361.
  8. Beaulieu C, Allen PS: Determinants of anisotropic water diffusion in nerves. Magn Reson Med 1994;31:394–400.
  9. McCarley RW, Wible CG, Frumin M, Hirayasu Y, Levitt JJ, Fischer IA, Shenton ME: MRI anatomy of schizophrenia. Biol Psychiatry 1999;45:1099–1119.
  10. Wible CG, Anderson J, Shenton ME, Kricun A, Hirayasu Y, Tanaka S, Levitt JJ, O’Donnell BF, Kikinis R, Jolesz FA, McCarley RW: Prefrontal cortex, negative symptoms, and schizophrenia: An MRI study. Psychiatry Res 2001;108:65–78.
  11. Hulshoff Pol HE, Schnack HG, Bertens MG, van Haren NE, van der Tweel I, Staal WG, Baare WF, Kahn RS: Volume changes in gray matter in patients with schizophrenia. Am J Psychiatry 2002;159:244–250.
  12. Buchsbaum MS: The frontal lobes, basal ganglia, and temporal lobes as sites for schizophrenia. Schizophr Bull 1990;16:379–389.
  13. Potkin SG, Alva G, Fleming K, Anand R, Keator D, Carreon D, Doo M, Jin Y, Wu JC, Fallon JH: A PET study of the pathophysiology of negative symptoms in schizophrenia. Positron emission tomography. Am J Psychiatry 2002;159:227–237.
  14. Lawrie SM, Buechel C, Whalley HC, Frith CD, Friston KJ, Johnstone EC: Reduced frontotemporal functional connectivity in schizophrenia associated with auditory hallucinations. Biol Psychiatry 2002;51:1008–1011.
  15. Paulus MP, Hozack NE, Zauscher BE, Frank L, Brown GG, McDowell J, Braff DL: Parietal dysfunction is associated with increased outcome-related decision-making in schizophrenia patients. Biol Psychiatry 2002;51:995–1004.
  16. Lim KO, Hedehus M, Moseley M, de Crespigny A, Sullivan EV, Pfefferbaum A: Compromised white matter tract integrity in schizophrenia inferred from diffusion tensor imaging. Arch Gen Psychiatry 1999;56:367–374.
  17. Foong J, Maier M, Clark CA, Barker GJ, Miller DH, Ron MA: Neuropathological abnormalities of the corpus callosum in schizophrenia: A diffusion tensor imaging study. J Neurol Neurosurg Psychiatry 2000;68:242–244.
  18. Kubicki M, Westin CF, Maier SE, Frumin M, Nestor PG, Salisbury DF, Kikinis R, Jolesz FA, McCarley RW, Shenton ME: Uncinate fasciculus findings in schizophrenia: A magnetic resonance diffusion tensor imaging study. Am J Psychiatry 2002;159:813–820.
  19. Hoptman MJ, Volavka J, Johnson G, Weiss E, Bilder RM, Lim KO: Frontal white matter microstructure, aggression, and impulsivity in men with schizophrenia: A preliminary study. Biol Psychiatry 2002;52:9–14.
  20. Agartz I, Andersson JL, Skare S: Abnormal brain white matter in schizophrenia: A diffusion tensor imaging study. Neuroreport 2001;12:2251–2254.
  21. Buchsbaum MS, Tang CY, Peled S, Gudbjartsson H, Lu D, Hazlett EA, Downhill J, Haznedar M, Fallon JH, Atlas SW: MRI white matter diffusion anisotropy and PET metabolic rate in schizophrenia. Neuroreport 1998;9:425–430.
  22. Hakak Y, Walker JR, Li C, Wong WH, Davis KL, Buxbaum JD, Haroutunian V, Fienberg AA: Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc Natl Acad Sci USA 2001;98:4746–4751.
  23. Tauscher J, Fischer P, Neumeister A, Rappelsberger P, Kasper S: Low frontal electroencephalographic coherence in neuroleptic-free schizophrenic patients. Biol Psychiatry 1998;44:438–447.
  24. Hirayasu Y, Potts GF, O’Donnell BF, Kwon JS, Arakaki H, Akdag SJ, Levitt JJ, Shenton ME, McCarley RW: Auditory mismatch negativity in schizophrenia: Topographic evaluation with a high-density recording montage. Am J Psychiatry 1998;155:1281–1284.
  25. Deicken RF, Zhou L, Corwin F, Vinogradov S, Weiner MW: Decreased left frontal lobe N-acetylaspartate in schizophrenia. Am J Psychiatry 1997;154:688–690.
  26. Jarema M, Choma M, Poniatowska R, Krawczyk R, Kozlowski P: Improvement criteria after neuroleptic treatment and clinical and neuroradiological factors in schizophrenic psychoses. Preliminary studies. Psychiatr Pol 1997;31:21–32.

Article / Publication Details

First-Page Preview
Abstract of Biological Psychiatry. Editor: J. Mendlewicz (Brussels) / Original Paper

Published online: May 21, 2003
Issue release date: May 2003

Number of Print Pages: 5
Number of Figures: 3
Number of Tables: 1

ISSN: 0302-282X (Print)
eISSN: 1423-0224 (Online)

For additional information: https://www.karger.com/NPS


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
TOP